These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 15010034

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of hormonal contraception on bone mineral density after 24 months of use.
    Berenson AB, Breitkopf CR, Grady JJ, Rickert VI, Thomas A.
    Obstet Gynecol; 2004 May; 103(5 Pt 1):899-906. PubMed ID: 15121563
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Bone mineral density in women aged 40-49 years using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraceptives for contraception.
    Beksinska ME, Smit JA, Kleinschmidt I, Farley TM, Mbatha F.
    Contraception; 2005 Mar; 71(3):170-5. PubMed ID: 15722065
    [Abstract] [Full Text] [Related]

  • 6. Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception.
    Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM.
    Arch Pediatr Adolesc Med; 2005 Feb; 159(2):139-44. PubMed ID: 15699307
    [Abstract] [Full Text] [Related]

  • 7. Bone mineral density in women using depot medroxyprogesterone acetate (DMPA) for at least 2 years compared to a control group: a cross sectional study.
    Pongsatha S, Ekmahachai M, Chaovisitsaree S, Suntornlimsiri N, Morakote N.
    J Med Assoc Thai; 2009 Oct; 92(10):1263-7. PubMed ID: 19845231
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Bone mineral density, fracture, and vitamin D in adolescents and young women using depot medroxyprogesterone acetate.
    Pitts SA, Feldman HA, Dorale A, Gordon CM.
    J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):23-6. PubMed ID: 22078997
    [Abstract] [Full Text] [Related]

  • 10. Forearm bone mineral density in postmenopausal former users of depot medroxyprogesterone acetate.
    Sanches L, Marchi NM, Castro S, Juliato CT, Villarroel M, Bahamondes L.
    Contraception; 2008 Nov; 78(5):365-9. PubMed ID: 18929732
    [Abstract] [Full Text] [Related]

  • 11. The association between depot medroxyprogesterone acetate contraception and bone mineral density in adolescent women.
    Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM.
    Contraception; 2004 Feb; 69(2):99-104. PubMed ID: 14759613
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Depot medroxyprogesterone acetate use after peak bone mass is associated with increased bone turnover but no decrease in bone mineral density.
    Walsh JS, Eastell R, Peel NF.
    Fertil Steril; 2010 Feb; 93(3):697-701. PubMed ID: 19013564
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Bone mineral density and depot medroxyprogesterone acetate.
    Albertazzi P, Bottazzi M, Steel SA.
    Contraception; 2006 Jun; 73(6):577-83. PubMed ID: 16730487
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.